Metropolis Healthcare Limited Financial Ratios
METROPOLIS · Healthcare · Current price ₹549.9
P/E ratio
59.8x
P/B ratio
8.2x
ROE
12.6%
ROCE
16.3%
Debt / Equity
0.15
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 59.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 8.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 12.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 16.3% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.15 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Metropolis Healthcare Limited's latest numbers.
Metropolis Healthcare Limited profitability
Metropolis Healthcare Limited generates a return on equity of 12.6% and a return on capital employed of 16.3%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.15 and a P/E of 59.8x, Metropolis Healthcare Limited is conservatively financed. Our overall business-quality score for the company is 4.9 / 10.
Understand the ratios
More on Metropolis Healthcare Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.